Published in Biomed Environ Mass Spectrom on February 01, 1986
Light suppresses melatonin secretion in humans. Science (1980) 3.45
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1983) 3.39
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Stress responses and metabolic regulation of glyceraldehyde-3-phosphate dehydrogenase genes in Arabidopsis. Plant Physiol (1993) 2.05
Evidence in favor of the symbiotic origin of chloroplasts: primary structure and evolution of tobacco glyceraldehyde-3-phosphate dehydrogenases. Cell (1986) 1.93
Glutaric aciduria; a "new" disorder of amino acid metabolism. Biochem Med (1975) 1.91
Mutations affecting two different steps in transcription initiation at the phage lambda PRM promoter. Proc Natl Acad Sci U S A (1983) 1.58
Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism. Nature (1984) 1.50
2-Amino-3-(methylamino)-propanoic acid (BMAA) in cycad flour: an unlikely cause of amyotrophic lateral sclerosis and parkinsonism-dementia of Guam. Neurology (1990) 1.40
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man. Can J Neurol Sci (1984) 1.36
Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J (1996) 1.32
Glutamate is a mediator of neurotoxicity in secretions of activated HIV-1-infected macrophages. J Neuroimmunol (2001) 1.31
Sources of the neurotoxin quinolinic acid in the brain of HIV-1-infected patients and retrovirus-infected macaques. FASEB J (1998) 1.23
Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience (1991) 1.23
Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse. Neuroscience (1992) 1.22
Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol (1992) 1.22
Human macrophages convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J (1992) 1.21
Preliminary psychometric evaluation of the Child Health Ratings Inventory (CHRIs) and Disease-Specific Impairment Inventory-Hematopoietic Stem Cell Transplantation (DSII-HSCT) in parents and children. Qual Life Res (2005) 1.21
MPTP toxicity: implications for research in Parkinson's disease. Annu Rev Neurosci (1988) 1.16
Differential effects of mutations on discrete steps in transcription initiation at the lambda PRE promoter. Cell (1983) 1.16
A mechanism for increased quinolinic acid formation following acute systemic immune stimulation. J Biol Chem (1993) 1.15
Characterization of cis-acting elements in light regulation of the nuclear gene encoding the A subunit of chloroplast isozymes of glyceraldehyde-3-phosphate dehydrogenase from Arabidopsis thaliana. Mol Cell Biol (1994) 1.14
Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain. FASEB J (1992) 1.14
Signaling events in the hypoxic induction of alcohol dehydrogenase gene in Arabidopsis. Plant Physiol (2001) 1.12
Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome. Ann Neurol (1989) 1.10
Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem (1987) 1.09
Characterization of branched monounsaturated hydrocarbons of Sarcina lutea and Sarcina flava. Lipids (1971) 1.08
Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J Neurochem (1993) 1.07
Simultaneous measurement of plasma 4-hydroxy-3-methoxyphenylethylene glycol and 3,4-dihydroxyphenylethylene glycol by gas chromatography mass spectrometry. Biomed Mass Spectrom (1981) 1.06
Mutations affecting induction of glycolytic and fermentative genes during germination and environmental stresses in Arabidopsis. Plant Physiol (1999) 1.06
Role of cII protein in stimulating transcription initiation at the lambda PRE promoter. Enhanced formation and stabilization of open complexes. J Mol Biol (1984) 1.06
Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation. J Neurochem (1993) 1.05
Kinetic analysis of mutations affecting the cII activation site at the PRE promoter of bacteriophage lambda. Proc Natl Acad Sci U S A (1984) 1.04
Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid. Brain Res (1992) 1.04
Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice. Brain Res (1991) 1.01
Effects of blue and red light on expression of nuclear genes encoding chloroplast glyceraldehyde-3-phosphate dehydrogenase of Arabidopsis thaliana. Plant Physiol (1993) 1.00
The role of lactic acid in autocrine B-cell growth stimulation. Proc Natl Acad Sci U S A (1991) 1.00
Antagonism of free-radical-induced damage of adlay seed and its antiproliferative effect in human histolytic lymphoma U937 monocytic cells. J Agric Food Chem (2001) 0.99
Lesions of the paraventricular nucleus area of the hypothalamus disrupt the suprachiasmatic leads to spinal cord circuit in the melatonin rhythm generating system. Brain Res Bull (1983) 0.98
Endozepine stupor. Recurring stupor linked to endozepine-4 accumulation. Brain (1998) 0.98
2-amino-3-(methylamino)-propanoic acid (BMAA) pharmacokinetics and blood-brain barrier permeability in the rat. J Pharmacol Exp Ther (1991) 0.98
Nonpolar lipid methylation. Biosynthesis of fatty acid methyl esters by rat lung membranes using S-adenosylmethionine. J Biol Chem (1981) 0.96
Identification of methoxyester artifacts produced by methanolic-HCI solvolysis of the cyclopropane fatty acids of the genus Yersinia. Biochim Biophys Acta (1974) 0.96
4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells). Biochem J (1993) 0.96
Quantitative metabolic profiling of urinary organic acids by gas chromatography-mass spectrometry: comparison of isolation methods. Anal Chem (1975) 0.95
Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem (2002) 0.93
Mutations that alter the DNA binding site for the bacteriophage lambda cII protein and affect the translation efficiency of the cII gene. J Mol Biol (1984) 0.93
Diagnosis of organic acidemias by gas chromatography--mass spectrometry. Lab Res Methods Biol Med (1981) 0.93
2-Amino-3 (methylamino)-propionic acid in cycad-derived foods is an unlikely cause of amyotrophic lateral sclerosis/parkinsonism. Lancet (1988) 0.92
Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects. Life Sci (1985) 0.92
Identification of a light-responsive region of the nuclear gene encoding the B subunit of chloroplast glyceraldehyde 3-phosphate dehydrogenase from Arabidopsis thaliana. Plant Physiol (1994) 0.91
Analysis of melatonin in human plasma by gas chromatography negative chemical ionization mass spectrometry. Science (1978) 0.90
Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey. Psychopharmacol Bull (1984) 0.90
Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat. Eur J Pharmacol (1984) 0.89
Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys. Life Sci (1985) 0.89
Quinolinic acid in the cerebrospinal fluid of children with symptomatic human immunodeficiency virus type 1 disease: relationships to clinical status and therapeutic response. J Infect Dis (1993) 0.89
Promoter analysis of the nuclear gene encoding the chloroplast glyceraldehyde-3-phosphate dehydrogenase B subunit of Arabidopsis thaliana. Plant Mol Biol (2001) 0.88
Kynurenine 3-hydroxylase in brain: species activity differences and effect of gerbil cerebral ischemia. Arch Biochem Biophys (1993) 0.88
Progressive slowing of reaction time and increasing cerebrospinal fluid concentrations of quinolinic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci (1992) 0.87
Species heterogeneity between gerbils and rats: quinolinate production by microglia and astrocytes and accumulations in response to ischemic brain injury and systemic immune activation. J Neurochem (1997) 0.87
Dihydrocaffeic acid: a common contaminant in the liquid chromatographic-electrochemical measurement of plasma catecholamines in man. J Chromatogr (1984) 0.87
Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma. Cancer Invest (2000) 0.87
Haemolytic disease of the newborn due to maternal irregular antibodies in the Chinese population in Taiwan. Transfus Med (2003) 0.87
(18O)quinolinic acid: its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid. Biomed Environ Mass Spectrom (1988) 0.87
Human RhDel is caused by a deletion of 1,013 bp between introns 8 and 9 including exon 9 of RHD gene. Blood (1998) 0.86
Disposition and metabolism of MHPG-CD3 in humans: plasma MHPG as the principal pathway of norepinephrine metabolism and as an important determinant of CSF levels of MHPG. Adv Biochem Psychopharmacol (1984) 0.86
Sustained increases in cerebrospinal fluid quinolinic acid concentrations in rhesus macaques (Macaca mulatta) naturally infected with simian retrovirus type-D. Brain Res (1990) 0.86
Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex. Brain Res (1989) 0.86
Quantification of the putative neurotoxin 2-amino-3-(methylamino)propanoic acid (BMAA) in cycadales: analysis of the seeds of some members of the family Cycadaceae. J Anal Toxicol (1990) 0.86
Molecular analysis of SMN, NAIP and P44 genes of SMA patients and their families. J Neurol Sci (2001) 0.85
Zinc, a neurotoxin to cultured neurons, contaminates cycad flour prepared by traditional guamanian methods. J Neurosci (1992) 0.85
Dopamine transporter regulation during four nights of REM sleep deprivation followed by recovery--an in vivo molecular imaging study in humans. Sleep (2010) 0.85
Parkinsonism induced by solvent abuse. Ann Neurol (1994) 0.84
Conversion of MHPG to vanillylmandelic acid. Implications for the importance of urinary MHPG. Arch Gen Psychiatry (1980) 0.83
Antidepressants reduce whole-body norepinephrine turnover while enhancing 6-hydroxymelatonin output. Arch Gen Psychiatry (1988) 0.83
Cerebral cortex and lung indoleamine-2,3-dioxygenase activity is increased in type-D retrovirus infected macaques. Brain Res (1991) 0.83
Gbetagamma affinity for bovine rhodopsin is determined by the carboxyl-terminal sequences of the gamma subunit. J Biol Chem (2001) 0.83
1-Methyl-4-phenylpyridine (MPP+) induces oxidative stress in the rodent. Life Sci (1986) 0.83
LC/MS analysis of NAD biosynthesis using stable isotope pyridine precursors. Anal Biochem (2002) 0.83
The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin Chim Acta (1985) 0.83
Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading. FEBS Lett (1989) 0.83
Cis-acting elements essential for light regulation of the nuclear gene encoding the A subunit of chloroplast glyceraldehyde 3-phosphate dehydrogenase in Arabidopsis thaliana. Plant Physiol (1996) 0.83
Quinolinic acid concentrations in brain and cerebrospinal fluid of patients with intractable complex partial seizures. Epilepsia (1990) 0.82
GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat. J Neurochem (1999) 0.82
Imipramine and desipramine in plasma and spinal fluid: relationship to clinical response and serotonin metabolism. Arch Gen Psychiatry (1978) 0.82
Facile oxidative decarboxylation of 3,4-dihydroxyphenylacetic acid catalyzed by copper and manganese ions. Biochim Biophys Acta (1996) 0.82
Genetic characterization of the rotaviruses associated with a nursery outbreak. J Med Virol (2001) 0.82
Mutation analysis of the putative tumor suppression gene PTEN/MMAC1 in sporadic breast cancer. Breast Cancer Res Treat (1999) 0.82
Hydrops foetalis caused by anti-Mur in first pregnancy--a case report. Transfus Med (2002) 0.81
2-Amino-3-(methylamino)propanoic acid (BMAA) bioavailability in the primate. Neurobiol Aging (1992) 0.81
Disposition and metabolism of MHPG in humans: application to studies in depression. Pharmacopsychiatry (1984) 0.81
Stimulation of the paraventricular nucleus area of the hypothalamus elevates urinary 6-hydroxymelatonin during daytime. Brain Res Bull (1987) 0.81
Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease. Neurosci Lett (1991) 0.81
Proteomic analysis of nuclei dissected from fixed rat brain tissue using expression microdissection. Anal Chem (2013) 0.81
DNA strand breakage, thymine glycol production, and hydroxyl radical generation induced by different samples of crystalline silica in vitro. Environ Res (1995) 0.81
Covalent binding of 3-pyridinealdehyde nicotinamide adenine dinucleotide and substrate to glyceraldehyde 3-phosphate dehydrogenase. J Biol Chem (1975) 0.80
Conjugated 3,4 dihydroxy phenyl acetic acid (DOPAC) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatment. Life Sci (1976) 0.80